JPRN-UMIN000004651招募中未知
Abatacept Research Outcome as a First-line Biological Agent in the Real World - ABROAD study
Division of Rheumatology Department of Internal Medicine, Hyogo College of Medicine0 个研究点目标入组 100 人开始时间: 2010年12月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who are inadequate by investigator's decision.
研究者
相似试验
已完成
不适用
ong-Term Outocomes With Abatacept In Biologic Treatment-Naive Rheumatoid Arthritis Patients In Japanese Clinical Practice Settingsrheumatoid arthritisJPRN-UMIN000021263Bristol-Myers Squibb K.K. Ono Pharmaceutical CO.,LTD.325
已完成
2 期
A pilot study examining the effect of abatacept in ANCA associated vasculitis (AAV)Wegener granulomatosisANCA Associated Vasculitis (AAV)100038161002321310047066NL-OMON31540Academisch Medisch Centrum4
进行中（未招募）
1 期
ARCADIA: Phase II proof of concept study of Abatacept (Orencia) in individuals who aRe Considered At risk of Developing Inflammatory ArthritisInflammatory arthritisMedDRA version: 20.0Level: PTClassification code 10003246Term: ArthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2015-005285-38-GBThe University of Leeds58
已完成
不适用
Analysis of Effectiveness and Safety of Abatacept in Japanese patients with Rheumatoid Arthritis.Rheumatoid arthritisJPRN-UMIN000005144Tokyo Medical and Dental university300
进行中（未招募）
2 期
A Phase II Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients With Undifferentiated Arthritis Who Are at High Risk for the Development of RAndifferentiated Arthritis (UA)Undifferentiated Arthritis (UA)Inflammatory and Immune System - Rheumatoid arthritisACTRN12605000785606Bristol-Myers Squibb Australia50